Back to results

Massachusetts Institute of Technology

Predicting Progression of Metabolic Dysfunction-associated Steatotic Liver Disease

Abstract

dc:description.abstract

This work focuses on the progression from metabolic dysfunction-associated fatty liver to metabolic dysfunction-associated steatohepatitis, a more serious prognosis that can lead to liver failure and death. Additional adverse progressed outcomes include hepatic failure, fibrosis, cirrhosis, and malignant neoplasm of liver and intrahepatic bile ducts. We explore the possibility of using different machine learning techniques, including logistic regression, XGBoost, random forest, and decision trees to predict the likelihood of progression. We use data from Massachusetts General Brigham to train our models, incorporating demographics, physical measurements, lab results, and doctor notes. As a result of this project, we our best model was an XGBoost classifier with an AUROC of 0.800 with random forest at a similar performance of 0.786. However, all of our models had low AUPRC and sensitivity, indicating both overfitting and an imbalanced dataset.

Degree

thesis:*
Name thesis:degree_name
Master
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Li, Jonathan
Advisor dc:contributor.advisor
  • Szolovits, Peter

Rights

dc:rights
Statement dc:rights
  • In Copyright - Educational Use Permitted
  • Copyright retained by author(s)

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1721.1/162692
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/162692

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

Li, Jonathan. Predicting Progression of Metabolic Dysfunction-associated Steatotic Liver Disease. Massachusetts Institute of Technology, 2025. https://hdl.handle.net/1721.1/162692